Compound Profile · GH Releasing
Mod GRF 1-29
Mod GRF 1-29 is a stabilised, short-acting GHRH analog studied in research for GH release with more natural pulsatile kinetics than extended-release alternatives.
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Well-characterised GHRH analog with favourable profile for GH research. Often synergised with GH secretagogues.
Reality check
What this isn't
- Not approved for human use — research-only context
- No regulator has approved human use
- Moderate evidence — replication still building
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full Mod GRF 1-29 review
A stabilised, short-acting GHRH analog (GHRH 1-29).
Designed to more closely approximate natural pulsatile GH stimulation than long-acting variants.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.
GH Releasing
CJC-1295
Why consider it: Related research-interest profile.
View profileGrowth Hormone
Ipamorelin + Mod GRF 1-29
Why consider it: Related research-interest profile.
View profileGH Secretagogue
Ipamorelin
Why consider it: Related research-interest profile.
View profile